论文部分内容阅读
采用双抗体夹心酶联免疫吸附试验（ＥＬＩＳＡ）检测再生障碍性贫血患者应用补肾泻肝方治疗前中后的血清ｓＩＬ－２Ｒ水平，分析其与疗效的关系。结果：有效病例治疗前中后的血清ｓＩＬ－２Ｒ值有明显差异（Ｐ＜００１～００５），且明显高于无效组（Ｐ＜００１～００５），显示有效组临床疗效与血清ｓＩＬ－２Ｒ值变化明显相关。结论：动态检测血清ｓＩＬ－２Ｒ水平可望成为监测再生障碍性贫血临床疗效的指标之一。
The level of serum sIL-2R in patients with aplastic anemia treated with Bu Shen Xie Gan Fang before and after treatment was detected by double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) and its relationship with efficacy was analyzed. Results: The serum levels of sIL-2R in effective cases were significantly different before and after treatment (P<001～005), and were significantly higher than those in the ineffective group (P<001～005), indicating effective groups. Clinical efficacy was significantly related to changes in serum sIL-2R. Conclusion: Dynamic detection of serum sIL-2R level is expected to be one of the indicators for monitoring the clinical efficacy of aplastic anemia.